NCT01468077View on ClinicalTrials.gov

A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Tocilizumab

8 mg/kg infusion

Trial Locations (8)

108

Reykjavik

2000

Frederiksberg

2900

Hellerup

4300

Holbæk

5000

Odense

5700

Svendborg

8600

Silkeborg

9000

Aalborg

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01468077 - A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment | Biotech Hunter | Biotech Hunter